Atlas Trials

Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53

Clinical trial NCT04966923 · COMPLETED

Trial details

NCT number
NCT04966923
Sponsor
Instituto do Cancer do Estado de São Paulo
Status
COMPLETED
Study type
OBSERVATIONAL
Breast CancerTP53 R337HLi-Fraumeni SyndromePrognosis Breast Cancer
Start date
2018-12-02
Primary completion
2021-08-07
Enrollment
135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.